-
© Sirisook – stock.adobe.com Germany to become Associate Member of SESAME
During a visit to the SESAME laboratory in Jordan on 15 November 2025, Dr Silke Launert, Parliamentary Secretary of State of the German Ministry for Research, Technology and Space, announced that Germany intends to become Associate Member of SESAME.
-
© Max-Planck-Gesellschaft Franz Rudolf Bienenfeld and the The Religion of the Non-Religious Jews
At an international research workshop organised by the Wiener Library and the Minerva Institute for German History, Anne Rethman presents the Austrian-Jewish legal scholar Franz Rudolf Bienenfeld.
-
© ODES / pikovit – stock.adobe.com Preliminary Announcement: EP MerMed Joint Transnational Call 2026
CARMEN 2026, a joint call by the European Partnership for Personalised Medicine (EP PerMed) adressing cardiovascular, metabolic, and kidney diseases, will open on 25 November 2025. Funding organisations from both Israel and Germany are involved in this call.
-
© Max-Planck-Gesellschaft New Max Planck Center brings together researchers from Freiburg and Jerusalem
On 11 November 2025, the Max Planck Center for Democracy, Security and Human Rights was inaugurated at the Hebrew University of Jerusalem. It tackles questions like: How can societies defend themselves without destroying the democratic and rule of law values they seek to protect?
-
© Nibroe Art – stock.adobe.com Six BIU Researchers Win Prestigious ISF-DFG Grants
Six outstanding researchers from Bar-Ilan University have been awarded the highly competitive ISF-DFG grant. The joint program of the Israel Science Foundation (ISF) and the German Research Foundation (DFG) represents a cornerstone of Israeli-German scientific partnership.
-
© Ekaterine – stock.adobe.com Thuringia’s Prime Minister Mario Voigt and high ranking delegation travel to Israel
Thuringia’s Minister-President Mario Voigt travels to Israel with a high-ranking delegation from 9 to 13 November 2025. The trip will take him to Tel Aviv and Jerusalem under the motto ‘Research. Innovation. Partnership / Thuringia and Israel – shaping the future, living solidarity and strengthening friendships’.
-
© catalin – stock.adobe.com Study finds protein target that could predict drug resistance in colon cancer
A German-Israeli research team has uncovered a promising new avenue in treating colorectal cancer, the world’s third leading cause of cancer-related deaths. The scientists identified a protein system that could open the door to more tailored, effective treatments.
-
© Shahid – stock.adobe.com German-Israeli research team investigates biofilms
Bacteria use surfaces to form complex heterogeneous communities known as biofilms. How these biofilms develop is the subject of a new international research project supported by the German Research Foundation (DFG) and the Israel Science Foundation (ISF).
-
© Gohgah – stock.adobe.com Novel technique shines light on next-gen nanomaterials: how MXenes truly work
Researchers from Israel and Germany have for the first time measured the true properties of individual MXene flakes — an exciting new nanomaterial with potential for better batteries, flexible electronics, and clean energy devices.
-
© Max-Planck-Gesellschaft Lou Bohlen presents the work of the Israel team at the Headquarters of the MPG
Lou Bohlen presented the Minerva team’s work during a presentation at the Max Planck Society, discussing the impact of the past two years of war on their operations. Over 70 participants attended, highlighting interest in their efforts.
